Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02793466
Title Durvalumab in Pediatric and Adolescent Patients
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Hospital Los Angeles
Indications

Advanced Solid Tumor

lymphoma

central nervous system cancer

Therapies

Durvalumab

Age Groups: child
Covered Countries USA


No variant requirements are available.